INSULIN LUDEFEN
UNII 2S3BP2LSQ2

Substance Identification & Data

This profile provides standardized clinical and technical data for Insulin Ludefen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2S3BP2LSQ2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2975655-22-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2S3BP2LSQ2

CAS Registry Number

2975655-22-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INSULIN LUDEFEN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13400

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Insulin Ludefen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INSULIN LUDEFEN

Common Names & Synonyms

(1A-21A),(1B-29B)-INSULIN (HUMAN), 14A-L-GLUTAMIC ACID-16B-L-HISTIDINE-25B-L-HISTIDINE-29B-(N6-(N-(21-CARBOXY-1-OXOHENEICOSYL)-L-.GAMMA.-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL)-L-LYSINE)-

HUMAN INSULIN (UNIPROT: P01308) B CHAIN, VARIANT (YB16>H, FB25>H, TB30>DEL)DISULFIDE BRIDGED TO HUMAN INSULIN A CHAIN, VARIANT (YA14>E) MODIFIED AT THE C-TERMINUS OF THE B CHAIN WITH N6.B29 -(N-(21-CARBOXYHENICOSANOYL)-L-.GAMMA.-GLUTAMYLDODECAKIS((2-(2-AMINOETHOXY)ETHOXY)ACETYL)), PRODUCED IN ESCHERICHIA COLI STRAIN W3110, NOT GLYCOSYLATED N6.B29-(N-(21-CARBOXYHENICOSANOYL)- L-.GAMMA.-GLUTAMYLDODECAKIS((2-(2-AMINOETHOXY)ETHOXY)ACETYL))(YA14 >E, YB16>H, FB25 >H)-B30-DES- L-THREONINE-INSULIN (HUMAN)

INSULIN LUDEFEN [INN]

External Clinical & Regulatory Resources

Previous UNII2S3988IBGV

Next UNII2S3E9ZT86Q